Skip to main content
Caplight Logo









ProAbTech Co., Ltd.

ProAbTech Co., Ltd.

Private
GwangjuHealthcare & Life Scienceshttps://proabtech.com/

Last Round

Series B

Feb 23, 2024

Total Funding Raised

$11.09M

Company Overview

ProAbTech Co., Ltd. is a biotechnology company that specializes in the development of next-generation bio-conjugate therapeutics using its proprietary site-specific protein-conjugation platforms, SelecAll and Albubody.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioconjugationdrug delivery platformlong-acting biologicsprotein therapeuticspeptide therapeuticsLYTAClysosome-targeting chimaerabiotech licensingdrug discoverynon-natural amino acidsbiotech R&Dprotein engineeringtherapeutic pipelinebiotech platformdrug modality

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProAbTech Co., Ltd. Comparables

Compare ProAbTech Co., Ltd. with similar companies based on industry and business-model similarity.

ProAbTech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Onegene Biotechnology
85%
AprilBio Co., Ltd.
77%
Sutro Biopharma Inc
76%

ProAbTech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 23, 2024
Series A ExtensionOct 25, 2021
Series AAug 10, 2020
SeedJun 1, 2019
SeedDec 1, 2017

ProAbTech Co., Ltd. Investors

Notable investors and investment history

ProAbTech Co., Ltd. investors
InvestorRounds
Widwin InvestmentSeries A
Hanwha Investment & SecuritiesSeries A, Series B
Albatross InvestmentSeries A
Hana SecuritiesSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2024

    $2.25M round led by BNC Korea Co. Ltd.

  • Oct 25, 2021

    $4.2M round led by Hana Securities.

ProAbTech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

ProAbTech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ProAbTech Co., Ltd.'s valuation, stock price, and market status.

Is ProAbTech Co., Ltd. a public or private company?

ProAbTech Co., Ltd. is a private company.

What is the current stock price of ProAbTech Co., Ltd.?

ProAbTech Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is ProAbTech Co., Ltd. worth (valuation)?

Valuation information for ProAbTech Co., Ltd. is not publicly available.

Can I buy ProAbTech Co., Ltd. stock?

ProAbTech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ProAbTech Co., Ltd.'s last funding round?

Funding round information for ProAbTech Co., Ltd. is not publicly available.

Who are the main investors in ProAbTech Co., Ltd.?

Investor information for ProAbTech Co., Ltd. is not publicly disclosed.

Will ProAbTech Co., Ltd. IPO soon?

No public IPO plans have been announced for ProAbTech Co., Ltd..

How can I track ProAbTech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProAbTech Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGwangju
Year Founded2017
Last FundingFeb 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?